Page 15 - Cell Technologies News Today

The global Autologous Cell Therapy market is forecasted to increase at a rate of 17.7% from $9.29 billion in 2019 to $35.64 billion in 2027, according to reportsanddata.com. The major factors attributing to the growth of the autologous cell therapy business are the rising incidence of chronic conditions such as autoimmune diseases, cancer, blood disorders, and others.

/PRNewswire/ -- The "Bioprocess Controllers and Automation Systems Market By Type of Controllers, Scale of Operation, Types of Processes Controlled, Mode of...

/PRNewswire/ -- The "Bioprocess Controllers and Automation Systems Market By Type of Controllers, Scale of Operation, Types of Processes Controlled, Mode of...

The "Cell Culture Global Market Report 2021: COVID-19 Growth and Change to 2030" report has been added to ResearchAndMarkets.com's offering. The global cell culture market is expected to grow from

/PRNewswire/ -- The 12th Colorado Gives Day on Tuesday, Dec. 7 raised a record-breaking $54,409,297 million for 3,063 participating Colorado nonprofits. Gifts...

/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that "embecta" [pronounced...

Medical technology company Terumo Blood and Cell Technologies and clinical-stage biotech Immunicom have signed a co-commercialisation agreement to advance a breast cancer therapy with potential to limit treatment–related adverse effects. Click to read more...

– In a dual-review process, two independent advisory committees to the Australian Minister for Health recommended reimbursement based on a...

Visiongain Published Global Stem Cell Technologies & Applications Market Report 2021-2031. Value Forecasts by Type (Allogenic, and Autologous), by...

/PRNewswire/ -- The "Global Cell Therapy Market Size, Share & Trends Analysis Report by Use-type, by Therapy Type (Autologous, Allogenic), by Region (North...